Positron Emission Tomography Scan Market Forecast 2032: AI-Driven Quantification and Reporting Tools

The positron emission tomography scan market is growing steadily as demand rises for precise diagnostic imaging across oncology, neurology, cardiology, and infectious disease care. PET scanners (including PET/CT and PET/MRI systems) provide metabolic and anatomical insights, enhancing early disease detection, treatment planning, and therapy monitoring. Growth drivers include increasing prevalence of chronic disorders like cancer and neurological conditions, technological advances (such as time-of-flight detectors, LSO crystals, and AI-enhanced imaging), and greater healthcare investments—especially in regions like North America and Asia‑Pacific. Challenges like high equipment costs, limited radiotracer access, and skilled staffing shortages remain, but ongoing innovation and policy support are expected to fuel steady market expansion globally.

According to Fortune Business Insights, the global positron emission tomography (PET) scan market was valued at USD 18.52 billion in 2024. The market is projected to grow from USD 19.31 billion in 2025 to USD 27.40 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period. In 2024, North America dominated the PET scan market with a market share of 50.59%.

Top Companies in the Market

• RadNet, Inc. (U.S.)
• Sonic Healthcare Limited (Australia)
• Akumin Inc. (U.S.)
• Apex Radiology (Australia)
• Alliance Medical Limited (U.K.)
• Novant Health (U.S.)
• InHealth Group (U.K.)
• Dignity Health (U.S.)
• Concord Medical (China)

Key Industry Development

In June 2024, AGFA HealthCare entered a strategic partnership with Alliance Medical to introduce an advanced cloud-based imaging solution across all Alliance Medical U.K. facilities. This technology collaboration reflects growing investment in digital infrastructure for PET imaging services .

Market Drivers & Restraints

Market Drivers

• Rising Prevalence of Chronic Diseases: The growing incidence of cancer, cardiovascular disease, neurological disorders (such as Alzheimer's and Parkinson’s) and epilepsy continues to boost the demand for PET scans for accurate diagnosis and treatment monitoring.
• Need for Accurate Early Diagnostics: Governments and healthcare providers worldwide are funding imaging research and infrastructure, supporting the uptake of PET scans in clinical settings.
• Hybrid Imaging Trends: Integrated PET/CT and PET/MRI systems are enhancing diagnostic precision and are being widely adopted in oncology, neurology, and cardiology.
• Advances in Radiotracer Technology: New tracers for molecular imaging and theranostics are enabling more personalized, accurate diagnostic and therapeutic decisions.
• AI & Machine Learning Integration: AI-based reconstruction and post-processing techniques are reducing scan time while improving image quality and clinical workflow efficiency .

Restraints

• Limited Reimbursement in Emerging Markets: Lack of insurance coverage in many developing regions restricts patient access to PET scans.
• High Equipment & Operational Costs: Expensive scanners, radiotracers, and maintenance limits adoption, especially in low-resource settings.
• Workforce Shortages: A significant scarcity of skilled radiographers and nuclear medicine specialists hinders broader deployment of PET imaging.

Market Report Coverage

The market report covers an extensive range of topics including market forecasts, growth drivers, emerging trends, restraints, and the evolving competitive landscape. It focuses on segmentation by indication, source of payment, service provider, and regional forecast from 2025 to 2032.

Competitive Landscape

The PET scan market consists of established diagnostics and healthcare services firms. Key players such as Sonic Healthcare, Apex Radiology, and Alliance Medical have built strong regional presences and continuously invest in strategic partnerships with academic and tech institutions.

Market Segments

By Indication

• Oncology: The leading segment due to the high global burden of cancer and extensive use of PET for staging, guiding therapy, and monitoring outcomes.
• Neurology: Used for diagnosing Alzheimer’s, epilepsy, and Parkinson’s disease.
• Cardiology: Employed to assess blood flow, ischemia, and myocardial viability.
• Others: Includes metabolic research, infection tracking, and musculoskeletal disorders.

By Source of Payment

• Private Insurance / Out-of-Pocket: Dominated the market in 2024 thanks to higher disposable incomes and increasing adoption of advanced diagnostics in developed regions.
• Public Health Insurance: Provides significant reach in countries with government-funded healthcare schemes.

By Service Provider

• Hospitals: Held the largest share in 2024, driven by extensive infrastructure, high patient volumes, and reimbursement support.
• Diagnostic Centers: Gaining traction through increased strategic investments and specialized PET scan offerings (e.g., Manipal TRUtest PET-CT launch in India, 2024).
• Others: Includes mobile imaging units, academic centers, and research laboratories.

Regional Insights

North America: Dominated the global market in 2024 with revenues of USD 9.73 billion (~50.59% market share), supported by advanced infrastructure and favorable reimbursement policies.

Europe: A major region in terms of PET adoption, with increasing scanner installations (e.g., France grew from 5 to 216 units between 2002 and 2022) and expanding diagnostic services.

Asia-Pacific: Projected to offer the fastest growth over the forecast period due to rising healthcare investments, growing chronic disease burden, and an aging population in countries such as China, India, and Japan.

Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/positron-emission-tomography-scan-market-111805 

Future Market Scope & Opportunities

• Continued growth is expected in hybrid imaging (PET/CT, PET/MRI) and molecular theranostic applications.
• AI-driven image analysis, digital workflow solutions, and cloud-based platforms like AGFA’s alliance with Alliance Medical will further modernize PET diagnostics.
• Emerging economies represent future growth headlines through scaled infrastructure and reimbursement expansion.
• Innovative tracer development and personalized medicine are setting new frontiers for PET scan utility across multiple indications.

Conclusion

The PET scan market is experiencing meaningful expansion driven by chronic disease burden, technological adoption, and infrastructure investments. With strong growth projected at a CAGR of 5.1% from 2025–2032, and revenues expected to surpass USD 27.40 billion, the industry represents a critical component of modern diagnostics. Leading firms, innovation in hybrid imaging, and expanding access across regions position the PET scan market for sustained success.

About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com